Dicot Pharma receives Notice of Allowance for patent application in the US
Uppsala, Sweden, October 11, 2024. Dicot Pharma announces today that the US Patent and Trademark Office (USPTO) has issued a Notice of Allowance for the company's patent application No. 18/196,049 entitled "New compounds and methods of their manufacturing". The Notice of Allowance means that USPTO intends to grant a US patent once certain formal steps are completed.Dicot Pharma AB has received a notice from the USPTO which means that one of the company's patent applications is intended to be approved in the USA after certain formal steps are completed. Once granted, the patent will be in